Sipai Health Technology Co., Ltd. stock analysis
Want to see HK:0314 full AI Analyst Report?
Sipai Health Technology Co., Ltd. (0314) Stock Price & Analysis
0314 Stock Chart & Stats
- Day’s Range
- HKD 1.54 - HKD 1.64
- 52-Week Range
- HKD 1.13 - HKD 3.03
- Previous Close
- HKD 1.56
- Volume
- N/A
- Average Volume (3M)
- 723.75K
- Market Cap
- HKD 916.73M
- Enterprise Value
- -HKD 18.20M
- Total Cash (Recent Filing)
- HKD 597.85M
- Total Debt (Recent Filing)
- HKD 24.70M
- Price to Earnings (P/E)
- ―
- Beta
- 0.24
- Next Earnings
- Mar 23, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Manageable Leverage
Recent leverage is low and equity remains positive, giving Sipai a comparatively stable financial base despite continued losses. This reduces near-term balance-sheet pressure and preserves flexibility to support operations, pursue growth initiatives, or absorb weaker trading conditions.
Improved Gross Margin
The improved gross margin indicates that product mix, pricing, or cost economics strengthened during 2025. Although profitability is not yet established, better unit economics and smaller losses can provide a foundation for future operating leverage if revenue stabilizes.
Operating Cash Flow Inflection
A return to positive operating cash flow is an encouraging sign that the business generated some cash from ongoing operations in 2025. If sustained, this could reduce reliance on external funding and improve the company’s ability to finance routine activities internally.
Bears Say
Sharp Revenue Contraction
A revenue contraction of this magnitude weakens scale, limits operating leverage, and makes a durable earnings recovery more difficult. Unless sales stabilize, the company may struggle to spread fixed costs across its business and convert improved margins into sustainable profitability.
Persistent Losses
Persistent operating and net losses show that the business has not yet demonstrated a consistently profitable model. Continued losses can consume equity, restrict investment capacity, and leave future improvement dependent on reversing both weak revenue performance and insufficient operating scale.
Fragile Cash Generation
Although operating cash flow improved, essentially breakeven free cash flow means Sipai still has limited internally funded capacity after investment needs. The history of negative free cash flow makes the recent improvement less established and leaves cash generation vulnerable if performance weakens.
Sipai Health Technology Co., Ltd. News
Sipai Health Redeems RMB50 Million Wealth Product to Fund Acquisition
The latest announcement is out from Sipai Health Technology Co., Ltd. ( ($HK:0314) ). Sipai Health Technology’s subsidiary, Sipai Healthcare Investment, has redeemed a principal‑guaranteed cash management wealth management product
Sipai Health Technology Discloses RMB80 Million Industrial Bank Wealth Product Subscriptions
Sipai Health Technology Co., Ltd. ( ($HK:0314) ) has shared an update. Sipai Health Technology, via its subsidiary Sipai Healthcare Investment, has subscribed to cash and fixed-income wealth management products
0314 FAQ
What was Sipai Health Technology Co., Ltd.’s price range in the past 12 months?
What is Sipai Health Technology Co., Ltd.’s market cap?
When is Sipai Health Technology Co., Ltd.’s upcoming earnings report date?
How were Sipai Health Technology Co., Ltd.’s earnings last quarter?
Is Sipai Health Technology Co., Ltd. overvalued?
Does Sipai Health Technology Co., Ltd. pay dividends?
What is Sipai Health Technology Co., Ltd.’s EPS estimate?
How many shares outstanding does Sipai Health Technology Co., Ltd. have?
What happened to Sipai Health Technology Co., Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Sipai Health Technology Co., Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Sipai Health Technology Co., Ltd. Stock Smart Score
Company Description
Sipai Health Technology Co., Ltd.
Sipai Health Technology Co., Ltd. is a Chinese enterprise specializing in medical technology and health management. Its business operations are diversified across three primary divisions: Specialty Pharmacy, Physician Research Assistance, and Health Insurance Services. The Specialty Pharmacy division manages a network of dedicated pharmacies and is also involved in the distribution of pharmaceutical products to drug manufacturers and other supply chain partners. Through its Physician Research Assistance segment, Sipai Health provides comprehensive site management organization (SMO) support to pharmaceutical firms and clinical research institutions. These services encompass a broad spectrum, including site identification and setup, patient acquisition and oversight, data and document handling, on-site logistical management of drugs and biosamples, and trial conclusion. Additionally, this segment offers specialized image management for clinical studies. The Health Insurance Services division functions as an intermediary, delivering brokerage solutions to various insurance providers. Established in 2014, the company's headquarters are situated in Guangzhou, China.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Xuguang Ma
- Employees
- 3,131
- Website
- www.medbankshealthtech.com
- Address
- Tower 1, Kerry Enterprise Center, Shanghai, SH, 200063, CN
Sipai Health Technology Co., Ltd. (0314) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 13 | 4 | 5 |
| Technical Analysis | 3 | 4 | 3 |
| Moving Averages | 10 | 0 | 2 |









